Preclinical Assessment in Juvenile Sheep of an Allogeneic Bone Tissue Engineering Product with Wharton’s Jelly Mesenchymal Stromal Cells
Secondary osteonecrosis (ON) is a common complication in paediatric cancer survivors. Combining multipotent mesenchymal stromal cells (MSCs) with core decompression surgery halts disease progression and stimulates bone regeneration. However, the success of advanced therapy medicinal products (ATMPs)...
Saved in:
| Main Authors: | Raquel Cabrera-Pérez, Irene Carreras-Sánchez, Ángela Roig-Molina, Alba López-Fernández, Irene Portas-Torres, Laura Batlle-Morera, Roberto Vélez, Joaquim Vives |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-06-01
|
| Series: | Cells |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2073-4409/14/12/862 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Enhancing adipogenesis in Wharton’s jelly multipotent mesenchymal stromal cells through lipidomic insights and fatty acid supplementation
by: Olena Rogulska, et al.
Published: (2025-08-01) -
The role of cytokine licensing in shaping the therapeutic potential of wharton’s jelly MSCs: metabolic shift towards immunomodulation at the expense of differentiation
by: Olena Rogulska, et al.
Published: (2025-04-01) -
Wharton’s jelly mesenchymal stromal cells derived from preterm umbilical cord reveal a hepatogenic potential
by: F. Timoneri, et al.
Published: (2025-06-01) -
Wharton’s Jelly Bioscaffolds Improve Cardiac Repair with Bone Marrow Mononuclear Stem Cells in Rats
by: Luize Kremer Gamba, et al.
Published: (2025-05-01) -
KORELASI LUAS AREA WHARTON’S JELLY DENGAN LUARAN BERAT LAHIR BAYI PADA KEHAMILAN CUKUP BULAN
by: Alem Pramudita Wibowo, et al.
Published: (2017-06-01)